Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
3:18cv1160 • June 4, 2018
Class Period Start
May 12, 2014
Class Period End
September 7, 2018
PSLRA Deadline
August 3, 2018
Case Allegations
10b5
Statutes of Repose
May 12, 2017
Country
United States
Court
Federal Court
Nov 13, 2018
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Sep 6, 2018
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jun 4, 2018
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in MABVAX THERAPEUTICS HOLDINGS, INC..
TOP
